Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Pneumonia Vaccine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Pneumonia Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Pneumonia Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Johnson & Johnson
By Type:
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
By End-User:
Pneumonia
Meningitis
Sepsis
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Pneumonia Vaccine Market
-
1.3 Market Segment by Type
-
1.3.1 China Pneumonia Vaccine Market Size and Growth Rate of Pneumococcal Conjugate Vaccine (PCV13) from 2016 to 2027
-
1.3.2 China Pneumonia Vaccine Market Size and Growth Rate of Pneumococcal Polysaccharide Vaccine (PPSV23) from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Pneumonia Vaccine Market Size and Growth Rate of Pneumonia from 2016 to 2027
-
1.4.2 China Pneumonia Vaccine Market Size and Growth Rate of Meningitis from 2016 to 2027
-
1.4.3 China Pneumonia Vaccine Market Size and Growth Rate of Sepsis from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Pneumonia Vaccine Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Pneumonia Vaccine by Major Types
-
3.4.1 Market Size and Growth Rate of Pneumococcal Conjugate Vaccine (PCV13)
-
3.4.2 Market Size and Growth Rate of Pneumococcal Polysaccharide Vaccine (PPSV23)
4 Segmentation of Pneumonia Vaccine Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Pneumonia Vaccine by Major End-Users
-
4.4.1 Market Size and Growth Rate of Pneumonia Vaccine in Pneumonia
-
4.4.2 Market Size and Growth Rate of Pneumonia Vaccine in Meningitis
-
4.4.3 Market Size and Growth Rate of Pneumonia Vaccine in Sepsis
5 Market Analysis by Regions
-
5.1 China Pneumonia Vaccine Production Analysis by Regions
-
5.2 China Pneumonia Vaccine Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Pneumonia Vaccine Landscape Analysis
-
6.1 North China Pneumonia Vaccine Landscape Analysis by Major Types
-
6.2 North China Pneumonia Vaccine Landscape Analysis by Major End-Users
7 Central China Pneumonia Vaccine Landscape Analysis
-
7.1 Central China Pneumonia Vaccine Landscape Analysis by Major Types
-
7.2 Central China Pneumonia Vaccine Landscape Analysis by Major End-Users
8 South China Pneumonia Vaccine Landscape Analysis
-
8.1 South China Pneumonia Vaccine Landscape Analysis by Major Types
-
8.2 South China Pneumonia Vaccine Landscape Analysis by Major End-Users
9 East China Pneumonia Vaccine Landscape Analysis
-
9.1 East China Pneumonia Vaccine Landscape Analysis by Major Types
-
9.2 East China Pneumonia Vaccine Landscape Analysis by Major End-Users
10 Northeast China Pneumonia Vaccine Landscape Analysis
-
10.1 Northeast China Pneumonia Vaccine Landscape Analysis by Major Types
-
10.2 Northeast China Pneumonia Vaccine Landscape Analysis by Major End-Users
11 Southwest China Pneumonia Vaccine Landscape Analysis
-
11.1 Southwest China Pneumonia Vaccine Landscape Analysis by Major Types
-
11.2 Southwest China Pneumonia Vaccine Landscape Analysis by Major End-Users
12 Northwest China Pneumonia Vaccine Landscape Analysis
-
12.1 Northwest China Pneumonia Vaccine Landscape Analysis by Major Types
-
12.2 Northwest China Pneumonia Vaccine Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Sanofi Pasteur
-
13.1.1 Sanofi Pasteur Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 CSL Limited
-
13.2.1 CSL Limited Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Emergent Biosolutions
-
13.3.1 Emergent Biosolutions Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Johnson & Johnson
-
13.4.1 Johnson & Johnson Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Pneumonia Vaccine Market Size and Growth Rate of Pneumococcal Conjugate Vaccine (PCV13) from 2016 to 2027
-
Figure China Pneumonia Vaccine Market Size and Growth Rate of Pneumococcal Polysaccharide Vaccine (PPSV23) from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Pneumonia Vaccine Market Size and Growth Rate of Pneumonia from 2016 to 2027
-
Figure China Pneumonia Vaccine Market Size and Growth Rate of Meningitis from 2016 to 2027
-
Figure China Pneumonia Vaccine Market Size and Growth Rate of Sepsis from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Pneumonia Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Pneumonia Vaccine Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Pneumonia Vaccine
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Pneumonia Vaccine by Different Types from 2016 to 2027
-
Table Consumption Share of Pneumonia Vaccine by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Pneumococcal Conjugate Vaccine (PCV13)
-
Figure Market Size and Growth Rate of Pneumococcal Polysaccharide Vaccine (PPSV23)
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Pneumonia Vaccine by Different End-Users from 2016 to 2027
-
Table Consumption Share of Pneumonia Vaccine by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Pneumonia
-
Figure Market Size and Growth Rate of Meningitis
-
Figure Market Size and Growth Rate of Sepsis
-
Table China Pneumonia Vaccine Production by Regions
-
Table China Pneumonia Vaccine Production Share by Regions
-
Figure China Pneumonia Vaccine Production Share by Regions in 2016
-
Figure China Pneumonia Vaccine Production Share by Regions in 2021
-
Figure China Pneumonia Vaccine Production Share by Regions in 2027
-
Table China Pneumonia Vaccine Consumption by Regions
-
Table China Pneumonia Vaccine Consumption Share by Regions
-
Figure China Pneumonia Vaccine Consumption Share by Regions in 2016
-
Figure China Pneumonia Vaccine Consumption Share by Regions in 2021
-
Figure China Pneumonia Vaccine Consumption Share by Regions in 2027
-
Table North China Pneumonia Vaccine Consumption by Types from 2016 to 2027
-
Table North China Pneumonia Vaccine Consumption Share by Types from 2016 to 2027
-
Figure North China Pneumonia Vaccine Consumption Share by Types in 2016
-
Figure North China Pneumonia Vaccine Consumption Share by Types in 2021
-
Figure North China Pneumonia Vaccine Consumption Share by Types in 2027
-
Table North China Pneumonia Vaccine Consumption by End-Users from 2016 to 2027
-
Table North China Pneumonia Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure North China Pneumonia Vaccine Consumption Share by End-Users in 2016
-
Figure North China Pneumonia Vaccine Consumption Share by End-Users in 2021
-
Figure North China Pneumonia Vaccine Consumption Share by End-Users in 2027
-
Table Central China Pneumonia Vaccine Consumption by Types from 2016 to 2027
-
Table Central China Pneumonia Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Central China Pneumonia Vaccine Consumption Share by Types in 2016
-
Figure Central China Pneumonia Vaccine Consumption Share by Types in 2021
-
Figure Central China Pneumonia Vaccine Consumption Share by Types in 2027
-
Table Central China Pneumonia Vaccine Consumption by End-Users from 2016 to 2027
-
Table Central China Pneumonia Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Pneumonia Vaccine Consumption Share by End-Users in 2016
-
Figure Central China Pneumonia Vaccine Consumption Share by End-Users in 2021
-
Figure Central China Pneumonia Vaccine Consumption Share by End-Users in 2027
-
Table South China Pneumonia Vaccine Consumption by Types from 2016 to 2027
-
Table South China Pneumonia Vaccine Consumption Share by Types from 2016 to 2027
-
Figure South China Pneumonia Vaccine Consumption Share by Types in 2016
-
Figure South China Pneumonia Vaccine Consumption Share by Types in 2021
-
Figure South China Pneumonia Vaccine Consumption Share by Types in 2027
-
Table South China Pneumonia Vaccine Consumption by End-Users from 2016 to 2027
-
Table South China Pneumonia Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure South China Pneumonia Vaccine Consumption Share by End-Users in 2016
-
Figure South China Pneumonia Vaccine Consumption Share by End-Users in 2021
-
Figure South China Pneumonia Vaccine Consumption Share by End-Users in 2027
-
Table East China Pneumonia Vaccine Consumption by Types from 2016 to 2027
-
Table East China Pneumonia Vaccine Consumption Share by Types from 2016 to 2027
-
Figure East China Pneumonia Vaccine Consumption Share by Types in 2016
-
Figure East China Pneumonia Vaccine Consumption Share by Types in 2021
-
Figure East China Pneumonia Vaccine Consumption Share by Types in 2027
-
Table East China Pneumonia Vaccine Consumption by End-Users from 2016 to 2027
-
Table East China Pneumonia Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure East China Pneumonia Vaccine Consumption Share by End-Users in 2016
-
Figure East China Pneumonia Vaccine Consumption Share by End-Users in 2021
-
Figure East China Pneumonia Vaccine Consumption Share by End-Users in 2027
-
Table Northeast China Pneumonia Vaccine Consumption by Types from 2016 to 2027
-
Table Northeast China Pneumonia Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Pneumonia Vaccine Consumption Share by Types in 2016
-
Figure Northeast China Pneumonia Vaccine Consumption Share by Types in 2021
-
Figure Northeast China Pneumonia Vaccine Consumption Share by Types in 2027
-
Table Northeast China Pneumonia Vaccine Consumption by End-Users from 2016 to 2027
-
Table Northeast China Pneumonia Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Pneumonia Vaccine Consumption Share by End-Users in 2016
-
Figure Northeast China Pneumonia Vaccine Consumption Share by End-Users in 2021
-
Figure Northeast China Pneumonia Vaccine Consumption Share by End-Users in 2027
-
Table Southwest China Pneumonia Vaccine Consumption by Types from 2016 to 2027
-
Table Southwest China Pneumonia Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Pneumonia Vaccine Consumption Share by Types in 2016
-
Figure Southwest China Pneumonia Vaccine Consumption Share by Types in 2021
-
Figure Southwest China Pneumonia Vaccine Consumption Share by Types in 2027
-
Table Southwest China Pneumonia Vaccine Consumption by End-Users from 2016 to 2027
-
Table Southwest China Pneumonia Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Pneumonia Vaccine Consumption Share by End-Users in 2016
-
Figure Southwest China Pneumonia Vaccine Consumption Share by End-Users in 2021
-
Figure Southwest China Pneumonia Vaccine Consumption Share by End-Users in 2027
-
Table Northwest China Pneumonia Vaccine Consumption by Types from 2016 to 2027
-
Table Northwest China Pneumonia Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Pneumonia Vaccine Consumption Share by Types in 2016
-
Figure Northwest China Pneumonia Vaccine Consumption Share by Types in 2021
-
Figure Northwest China Pneumonia Vaccine Consumption Share by Types in 2027
-
Table Northwest China Pneumonia Vaccine Consumption by End-Users from 2016 to 2027
-
Table Northwest China Pneumonia Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Pneumonia Vaccine Consumption Share by End-Users in 2016
-
Figure Northwest China Pneumonia Vaccine Consumption Share by End-Users in 2021
-
Figure Northwest China Pneumonia Vaccine Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi Pasteur
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur
-
Figure Sales and Growth Rate Analysis of Sanofi Pasteur
-
Figure Revenue and Market Share Analysis of Sanofi Pasteur
-
Table Product and Service Introduction of Sanofi Pasteur
-
Table Company Profile and Development Status of CSL Limited
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Limited
-
Figure Sales and Growth Rate Analysis of CSL Limited
-
Figure Revenue and Market Share Analysis of CSL Limited
-
Table Product and Service Introduction of CSL Limited
-
Table Company Profile and Development Status of Emergent Biosolutions
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent Biosolutions
-
Figure Sales and Growth Rate Analysis of Emergent Biosolutions
-
Figure Revenue and Market Share Analysis of Emergent Biosolutions
-
Table Product and Service Introduction of Emergent Biosolutions
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
